Cancer Family

Hematopoietic and Lymphoid Cell Neoplasm

HematologicNon-malignant4,231 active trials98 approved drugs1,009 evidence items

NCIt: C27134
DOID: 2531
MeSH: D019337

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (735)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 76–100 of 735 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

De-escalation trials in multiple myeloma: past, present and future.
Hira Mian, Luciano J Costa, Mohamad Mohty et al. · Nat Rev Clin Oncol · Oct 1, 2026 · PMID 42527555 · candidate dictionary pubmed
Cytogenetics-based clinical trajectories in patients with MRD negativity post autologous transplant for multiple myeloma.
Estefania Gauto Mariotti, Shaji Kumar, Wilson Gonsalves et al. · Leukemia · Oct 1, 2026 · PMID 42481797 · candidate dictionary pubmed
Multiple myeloma diagnosed after contrast-enhanced computed tomography without renal complications: a case report with literature review.
Keiko Kudoh, Takaharu Kudoh, Yasuhiko Morita et al. · Oral Radiol · Oct 1, 2026 · PMID 42479293 · candidate dictionary pubmed
Clinical and Metabolic Outcomes of Radiofrequency Ablation with Vertebral Augmentation for Symptomatic Spinal Osteolytic Lesions in Multiple Myeloma.
Pooya Torkian, Jens Hillengass, Younes Jahangiri et al. · J Vasc Interv Radiol · Oct 1, 2026 · PMID 42468838 · candidate dictionary pubmed
Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.
Vasiliki Kostiou, Vijayalakshmi Chelliah, Piet H van der Graaf et al. · Clin Pharmacol Ther · Oct 1, 2026 · PMID 42364971 · candidate dictionary pubmed
Efficiency of Automated and Manual Plasma Cell Immunoselection for FISH Analysis in Multiple Myeloma.
Helena Podgornik, Katarina Reberšek · Int J Lab Hematol · Oct 1, 2026 · PMID 42332409 · candidate dictionary pubmed

Bispecific Antibodies in Multiple Myeloma: A Concise Review of Current Treatments.

Amir M Ansari, Sogol Attaripour, Sahil Garg et al. · Cancer Invest · Oct 1, 2026 · PMID 42323950 · candidate dictionary pubmed

Energy-resolved attenuation behaviour on dual-source photon-counting CT: Implications for quantitative assessment of femoral bone marrow in multiple myeloma.

Anke Heidemeier, Franzisca Scheiner, Henner Huflage et al. · Eur J Radiol · Oct 1, 2026 · PMID 42289153 · candidate dictionary pubmed

Promoter Methylation of HOXA5 and NDRG2 in Multiple Myeloma Patients with Renal Impairment.

Riham Abdel-Hamid Haroun, Dina Samir Elsaid, Mona A Al-Dosoky et al. · Biochem Genet · Oct 1, 2026 · PMID 42258087 · candidate dictionary pubmed

Junctional Adhesion Molecule-A (JAM-A) Associates With High-Risk Disease in Multiple Myeloma Patients and a Structure-Based Rationally-Designed Peptide Inhibitor Attenuates Tumorigenic Features In Vitro and In Vivo.

Niamh McAuley, Roisin McAvera, Dimitri Bong et al. · Eur J Haematol · Oct 1, 2026 · PMID 42204384 · candidate dictionary pubmed

Photon-counting detector computed tomography (PCD-CT) in multiple myeloma: a systematic review and trial sequential meta-analysis on image quality and radiation dose.

Victor Arthur Ohannesian, Bruna Colabono Taneja, Adham do Amaral E Castro et al. · Skeletal Radiol · Oct 1, 2026 · PMID 42204008 · candidate dictionary pubmed

Circadian Deregulation in Multiple Myeloma: BMAL1/CLOCK Expression Patterns and Diagnostic Performance.

Hamide Albayrak, Mustafa Ertan Ay, Anıl Tombak et al. · Int J Lab Hematol · Oct 1, 2026 · PMID 42167790 · candidate dictionary pubmed

Condensed vs. Standard Step-Up Dosing Schedule of Talquetamab in Relapsed/Refractory Multiple Myeloma.

Grace Elsey, James A Davis, Kelley Julian et al. · Eur J Haematol · Oct 1, 2026 · PMID 42150762 · candidate dictionary pubmed

Sustained IL-15 release enhances CAR-T therapy in multiple myeloma via FOXO1 signaling axis activation.

Kuai Yu, Yunxin Zeng, Bo Lu et al. · Biomaterials · Oct 1, 2026 · PMID 41936184 · candidate dictionary pubmed

Safety, effectiveness and pharmacokinetics of high-dose propylene glycol-free melphalan (EVOMELA) with a prolonged infusion as myeloablative conditioning in Chinese multiple myeloma patients undergoing autologous stem cell transplantation: A prospective phase iv study.

Fengrong Wang, Zhen Cai, Dehui Zou et al. · J Oncol Pharm Pract · Oct 1, 2026 · PMID 40296724 · candidate dictionary pubmed

Targeting the Epigenetic-Immune Axis in Acute Myeloid Leukemia: Current Advances and Future Directions.

Devangi Ghosh, Mohd Ayoub, Surajit Karmakar et al. · Curr Oncol Rep · Sep 29, 2026 · PMID 42809184 · candidate dictionary pubmed

Repurposing the Neurokinin-1 receptor antagonist Aprepitant to eradicate relapsed/refractory acute lymphoblastic leukemia via mitochondria-driven necroptosis.

Gang Shao, Hanling Pan, Jiayi Zhu et al. · Cancer Lett · Sep 28, 2026 · PMID 42184918 · candidate dictionary pubmed

Renal risk differences between diffuse large B-cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: implications for supportive oncology care.

Syed E Pasha, Sumon Khalique, Rakahn Haddadin et al. · Support Care Cancer · Sep 28, 2026 · PMID 42806171 · candidate dictionary pubmed

Diagnostic yield of cancer predisposition in a nationwide prospective childhood acute leukemia cohort.

Fulya Taylan, Anna Staffas, Sara Sjögren et al. · Nat Commun · Sep 28, 2026 · PMID 42806009 · candidate dictionary pubmed

Abemaciclib and lenalidomide presenting with central retinal artery occlusion in a patient with breast cancer and multiple myeloma: a possible treatment-related association.

Manas Pustake, Stevenson Ongsyping, Jesus Gomez et al. · BMJ Case Rep · Sep 28, 2026 · PMID 42805625 · candidate dictionary pubmed

Machine learning-driven M2 macrophage signature for precision prediction of survival and therapy response in acute myeloid leukemia.

Fangmin Zhong, Jing Liu, Jingze Yue et al. · Inflamm Res · Sep 27, 2026 · PMID 42802232 · candidate dictionary pubmed

ATM mutations in myelodysplastic neoplasms, acute myeloid leukemia, and myeloproliferative neoplasms: a systematic review.

Lucas Oliveira Laurindo, Marjori Lima Boblitz Parente, Greyce Luri Sasahara et al. · Med Oncol · Sep 25, 2026 · PMID 42789026 · candidate dictionary pubmed

MLN4924 promotes the transcriptional activation of BTG2 via the ROS/EGR1-mediated signaling axis to suppress acute myeloid leukemia progression.

Xiao Tang, Jinli Jian, Yuancheng Guo et al. · Acta Biochim Biophys Sin (Shanghai) · Sep 25, 2026 · PMID 41496600 · candidate dictionary pubmed

Venetoclax plus pediatric regimen in adolescents and adults with Ph-negative acute lymphoblastic leukemia.

Xiaoyuan Gong, Yuntao Liu, Qiuyun Fang et al. · Blood · Sep 24, 2026 · PMID 42166560 · candidate dictionary pubmed

NSD2 degradation remediates the oncogenic cistrome in t(4;14) multiple myeloma.

Bo Hu, Jacob T Edwards, Hardik Modi et al. · Blood · Sep 24, 2026 · PMID 42371798 · candidate dictionary pubmed